{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:32:05Z","timestamp":1772119925782,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["ZIADK075063"],"award-info":[{"award-number":["ZIADK075063"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["ZIADK031117"],"award-info":[{"award-number":["ZIADK031117"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s11302-023-09924-3","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T15:12:39Z","timestamp":1676301159000},"page":"551-564","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vivo phenotypic validation of adenosine receptor-dependent activity of non-adenosine drugs"],"prefix":"10.1007","volume":"19","author":[{"given":"Cuiying","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana","family":"Gavrilova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Lewicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc L.","family":"Reitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"issue":"4","key":"9924_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrd3955","volume":"12","author":"JF Chen","year":"2013","unstructured":"Chen JF, Eltzschig HK, Fredholm BB (2013) Adenosine receptors as drug targets\u2013what are the challenges? Nat Rev Drug Discov 12(4):265\u2013286","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"9924_CR2","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","volume":"98","author":"PA Borea","year":"2018","unstructured":"Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K (2018) Pharmacology of adenosine receptors: the state of the art. Physiol Rev 98(3):1591\u20131625","journal-title":"Physiol Rev"},{"issue":"11","key":"9924_CR3","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/17460441.2018.1534825","volume":"13","author":"M Congreve","year":"2018","unstructured":"Congreve M, Brown GA, Borodovsky A, Lamb ML (2018) Targeting adenosine A2A receptor antagonism for treatment of cancer. Exp Opin Drug Discov 13(11):997\u20131003. https:\/\/doi.org\/10.1080\/17460441.2018.1534825","journal-title":"Exp Opin Drug Discov"},{"key":"9924_CR4","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.3390\/ijms20205139","volume":"20","author":"ZG Gao","year":"2019","unstructured":"Gao ZG, Jacobson KA (2019) A2B adenosine receptor and cancer. Int J Mol Sci 20:5139","journal-title":"Int J Mol Sci"},{"key":"9924_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fncel.2019.00124","volume":"13","author":"KA Jacobson","year":"2019","unstructured":"Jacobson KA, Tosh DK, Jain S, Gao ZG (2019) Historical and current adenosine receptor agonists in preclinical and clinical development. Frontiers Cell Neurosci 13:124. https:\/\/doi.org\/10.3389\/fncel.2019.00124","journal-title":"Frontiers Cell Neurosci"},{"key":"9924_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","volume":"13","author":"B Cronstein","year":"2017","unstructured":"Cronstein B, Sitkovsky M (2017) Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. Nat Rev Rheumatol 13:41\u201351","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"9924_CR7","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3390\/cells9061509","volume":"9","author":"L Antonioli","year":"2020","unstructured":"Antonioli L, Lucarini E, Lambertucci C, Fornai M, Pellegrini C, Benvenuti L et al (2020) The anti-Inflammatory and pain-relieving effects of AR170, an adenosine A3 receptor agonist, in a rat model of colitis. Cells 9(6):1509","journal-title":"Cells"},{"key":"9924_CR8","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3390\/cells9040956","volume":"9","author":"KA Jacobson","year":"2020","unstructured":"Jacobson KA, Reitman ML (2020) Adenosine-related mechanisms in non-adenosine receptor drugs. Cells 9:956","journal-title":"Cells"},{"key":"9924_CR9","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1016\/j.bmcl.2008.03.075","volume":"18","author":"RJ Gillespie","year":"2008","unstructured":"Gillespie RJ, Adams DR, Bebbington D, Benwell K, Cliffe IA, Dawson CE, Dourish CT, Fletcher A, Gaur S, Giles PR, Jordan AM, Knight AR, Knutsen LJS, Lawrence A, Lerpiniere J, Misra A, Porter RHP, Pratt RM, Shepherd R, Upton R, Ward SE, Weiss SM, Williamson DS (2008) Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives. Bioorg Med Chem Lett 18:2916\u20132919","journal-title":"Bioorg Med Chem Lett"},{"key":"9924_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/0006-2952(88)90139-6","volume":"37","author":"JW Daly","year":"1988","unstructured":"Daly JW, Hong O, Padgett WL, Shamim MT, Jacobson KA, Ukena D (1988) Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptors. Biochem Pharmacol 37:655\u2013664","journal-title":"Biochem Pharmacol"},{"key":"9924_CR11","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1021\/jm901647p","volume":"53","author":"V Katritch","year":"2010","unstructured":"Katritch V, Jaakola VP, Lane JR, Lin J, IJzerman AP, Yeager M, Kufareva I, Stevens RC, Abagyan R (2010) Structure-based discovery of novel chemotypes for adenosine A2A receptor antagonists. J Med Chem 53:1799\u20131809","journal-title":"J Med Chem"},{"key":"9924_CR12","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1021\/acschembio.6b00357","volume":"11","author":"D Rodr\u00edguez","year":"2016","unstructured":"Rodr\u00edguez D, Chakraborty S, Warnick E, Crane S, Gao ZG, O\u2019Connor RO, Jacobson KA, Carlsson J (2016) Structure-based screening of uncharted chemical space for atypical adenosine receptor agonists. ACS Chem Biol 11:2763\u20132772","journal-title":"ACS Chem Biol"},{"issue":"4","key":"9924_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/0006-2952(88)90139-6","volume":"37","author":"JW Daly","year":"1988","unstructured":"Daly JW, Hong O, Padgett WL, Shamim MT, Jacobson KA, Ukena D (1988) Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptors. Biochem Pharmacol 37(4):655\u2013664","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"9924_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0278-5846(88)90100-5","volume":"12","author":"JW Phillis","year":"1988","unstructured":"Phillis JW, O\u2019Regan MH (1988) The role of adenosine in the central actions of the benzodiazepines. Prog Neuropsychopharmacol Biol Psychiatry 12(4):389\u2013404","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9924_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-1-4757-5235-9_15","volume":"505","author":"KA Jacobson","year":"2002","unstructured":"Jacobson KA, Moro S, Manthey JA, West PL, Ji XD (2002) Interactions of flavones and other phytochemicals with adenosine receptors. Adv Exp Med Biol 505:163\u2013171","journal-title":"Adv Exp Med Biol"},{"issue":"15","key":"9924_CR16","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1021\/jm9600205","volume":"39","author":"AM van Rhee","year":"1996","unstructured":"van Rhee AM, Jiang JL, Melman N, Olah ME, Stiles GL, Jacobson KA (1996) Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors. J Med Chem 39(15):2980\u20132989","journal-title":"J Med Chem"},{"issue":"6","key":"9924_CR17","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/sj.jid.5700286","volume":"126","author":"MP Schon","year":"2006","unstructured":"Schon MP, Schon M, Klotz KN (2006) The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion. J Invest Dermatol 126(6):1338\u20131347","journal-title":"J Invest Dermatol"},{"key":"9924_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/15257770.2016.1210805","volume":"36","author":"RC Boswell-Casteel","year":"2017","unstructured":"Boswell-Casteel RC, Hays FA (2017) Equilibrative nucleoside transporters\u2014a review. Nucleosides, Nucleotides Nucleic Acids 36:7\u201330. https:\/\/doi.org\/10.1080\/15257770.2016.1210805","journal-title":"Nucleosides, Nucleotides Nucleic Acids"},{"key":"9924_CR19","doi-asserted-by":"publisher","first-page":"113747","DOI":"10.1016\/j.bcp.2019.113747","volume":"172","author":"A Vlachodimou","year":"2020","unstructured":"Vlachodimou A, Konstantinopoulou K, IJzerman AP, Heitman LH, (2020) Affinity, binding kinetics and functional characterization of draflazine analogues for human equilibrative nucleoside transporter 1 (SLC29A1). Biochem Pharmacol 172:113747","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"9924_CR20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1124\/pr.112.006361","volume":"65","author":"D Boison","year":"2013","unstructured":"Boison D (2013) Adenosine kinase: exploitation for therapeutic gain. Pharmacol Rev 65(3):906\u2013943","journal-title":"Pharmacol Rev"},{"key":"9924_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1074248413511693","volume":"19","author":"C Armstrong","year":"2014","unstructured":"Armstrong C, Summers L, Ewart S, Nylander JE, van Sidaway JJ, Giezen. (2014) Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1. J Cardiovasc Pharmacol Ther 19:209\u2013219","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"23","key":"9924_CR22","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.jacc.2014.03.031","volume":"63","author":"M Cattaneo","year":"2014","unstructured":"Cattaneo M, Schulz R, Nylander S (2014) Adenosine-mediated effects of ticagrelor: Evidence and potential clinical relevance. J Am Coll Cardiol 63(23):2503\u20132509","journal-title":"J Am Coll Cardiol"},{"key":"9924_CR23","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1073\/pnas.0511232103","volume":"103","author":"EJ Carrier","year":"2006","unstructured":"Carrier EJ, Auchampach JA, Hillard CJ (2006) Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci USA 103:7895\u20137900","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5 Pt 1","key":"9924_CR24","doi-asserted-by":"publisher","first-page":"C1175","DOI":"10.1152\/ajpcell.1992.262.5.C1175","volume":"262","author":"LE Nagy","year":"1992","unstructured":"Nagy LE (1992) Ethanol metabolism and inhibition of nucleoside uptake lead to increased extracellular adenosine in hepatocytes. Am J Physiol 262(5 Pt 1):C1175\u2013C1180","journal-title":"Am J Physiol"},{"key":"9924_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.taap.2016.12.021","volume":"317","author":"LR Ribeiro","year":"2017","unstructured":"Ribeiro LR, Storer RI (2017) A semi-quantitative translational pharmacology analysis to understand the relationship between in vitro ENT1 inhibition and the clinical incidence of dyspnoea and bronchospasm. Toxicol Appl Pharmacol 317:41\u201350","journal-title":"Toxicol Appl Pharmacol"},{"key":"9924_CR26","first-page":"168","volume":"65","author":"H Tian","year":"2007","unstructured":"Tian H, Cronstein BN (2007) Understanding the mechanisms of action of methotrexate implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Joint Dis 65:168\u2013173","journal-title":"Bull NYU Hosp Joint Dis"},{"issue":"3","key":"9924_CR27","doi-asserted-by":"publisher","first-page":"e3000161","DOI":"10.1371\/journal.pbio.3000161","volume":"17","author":"C Xiao","year":"2019","unstructured":"Xiao C, Liu N, Jacobson KA, Gavrilova O, Reitman ML (2019) Physiology and effects of nucleosides in mice lacking all four adenosine receptors. PLoS Biol 17(3):e3000161","journal-title":"PLoS Biol"},{"key":"9924_CR28","doi-asserted-by":"publisher","first-page":"114367","DOI":"10.1016\/j.bcp.2020.114367","volume":"187","author":"CR Lopes","year":"2021","unstructured":"Lopes CR, Louren\u00e7o VS, Tom\u00e9 \u00c2R, Cunha RA, Canas PM (2021) Use of knockout mice to explore CNS effects of adenosine. Biochem Pharmacol 187:114367. https:\/\/doi.org\/10.1016\/j.bcp.2020.114367","journal-title":"Biochem Pharmacol"},{"key":"9924_CR29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1124\/jpet.115.229872","volume":"356","author":"JL Carlin","year":"2016","unstructured":"Carlin JL, Tosh DK, Xiao C, Pi\u00f1ol RA, Chen Z, Salvemini D, Gavrilova O, Jacobson KA, Reitman ML (2016) Peripheral adenosine A3 receptor activation causes regulated hypothermia in mice that is dependent on central histamine H1 receptors. J Pharmacol Exp Therap 356:474\u2013482","journal-title":"J Pharmacol Exp Therap"},{"key":"9924_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuropharm.2016.11.026","volume":"114","author":"JL Carlin","year":"2017","unstructured":"Carlin JL, Jain S, Gizewski E, Wan TC, Tosh DK, Xiao C, Auchampach JA, Jacobson KA, Gavrilova O, Reitman ML (2017) Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms. Neuropharmacology 114:101\u2013113","journal-title":"Neuropharmacology"},{"issue":"4","key":"9924_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.jcbfm.9600218","volume":"26","author":"PM Kochanek","year":"2006","unstructured":"Kochanek PM, Vagni VA, Janesko KL, Washington CB, Crumrine PK, Garman RH et al (2006) Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J Cereb Blood Flow Metab 26(4):565\u2013575","journal-title":"J Cereb Blood Flow Metab"},{"key":"9924_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.neuropharm.2018.02.035","volume":"139","author":"JL Carlin","year":"2018","unstructured":"Carlin JL, Jain S, Duroux R, Suresh RR, Xiao C, Auchampach JA et al (2018) (2018) Activation of adenosine A2A or A2B receptors causes hypothermia in mice. Neuropharmacology 139:268\u2013278","journal-title":"Neuropharmacology"},{"key":"9924_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1432-1033.1985.tb08989.x","volume":"150","author":"J Striessnig","year":"1985","unstructured":"Striessnig J, Zernig G, Glossmann H (1985) Glossmann Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter. Eur J Biochem 150:67\u201377","journal-title":"Eur J Biochem"},{"issue":"1","key":"9924_CR34","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1046\/j.1523-1755.1998.00727.x","volume":"53","author":"R Guieu","year":"1998","unstructured":"Guieu R, Dussol B, Devaux C, Sampol J, Brunet P, Rochat H et al (1998) Interactions between cyclosporine A and adenosine in kidney transplant recipients. Kidney Int 53(1):200\u2013204","journal-title":"Kidney Int"},{"issue":"2","key":"9924_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0022-2143(02)00022-7","volume":"140","author":"J Spychala","year":"2002","unstructured":"Spychala J, Mitchell BS (2002) Cyclosporin A and FK506 decrease adenosine kinase activity and adenosine uptake in T-lymphocytes. J Lab Clin Med 140(2):84\u201391","journal-title":"J Lab Clin Med"},{"key":"9924_CR36","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.1167\/iovs.08-2196","volume":"49","author":"GI Liou","year":"2008","unstructured":"Liou GI, Auchampach JA, Hillard CJ, Zhu G, Yousufzai B, Mian S, Khan S, Khalifa Y (2008) Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor. Investig Ophthalmol Vis Sci 49:5526\u20135531","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"9924_CR37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","volume":"37","author":"A Castillo","year":"2010","unstructured":"Castillo A, Tol\u00f3n MR, Fern\u00e1ndez-Ruiz J, Romero J, Martinez-Orgado J (2010) The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic\u2013ischemic brain damage in mice is mediated by CB2 and adenosine receptors. Neurobiol Dis 37:434\u2013440","journal-title":"Neurobiol Dis"},{"key":"9924_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neures.2014.04.006","volume":"84","author":"S Mijangos-Moreno","year":"2014","unstructured":"Mijangos-Moreno S, Poot-Ak\u00e9 A, Arankowsky-Sandoval G, Murillo-Rodr\u00edguez E (2014) Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats. Neurosci Res 84:60\u201363","journal-title":"Neurosci Res"},{"key":"9924_CR39","doi-asserted-by":"publisher","unstructured":"Vitale RM, Iannotti FA, Amodeo P (2021) The (poly)pharmacology of cannabidiol in neurological and neuropsychiatric disorders: molecular mechanisms and targets. Int J Mol Sci 22(9):4876.\u00a0https:\/\/doi.org\/10.3390\/ijms22094876","DOI":"10.3390\/ijms22094876"},{"key":"9924_CR40","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/eurheartj\/ehp555","volume":"31","author":"K Schmidt","year":"2010","unstructured":"Schmidt K, Tissier R, Ghaleh B, Drogies T, Felix SB, Krieg T (2010) Cardioprotective effects of mineralocorticoid receptor antagonists at reperfusion. Eur Heart J 31:1655\u20131662","journal-title":"Eur Heart J"},{"issue":"3","key":"9924_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neulet.2010.06.025","volume":"480","author":"HG Lee","year":"2010","unstructured":"Lee HG, Kim WM, Choi JI, Yoon MH (2010) Roles of adenosine receptor subtypes on the antinociceptive effect of sildenafil in rat spinal cord. Neurosci Lett 480(3):182\u2013185","journal-title":"Neurosci Lett"},{"issue":"3","key":"9924_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0306-3623(86)90038-8","volume":"17","author":"TH Swanson","year":"1986","unstructured":"Swanson TH, Green CL (1986) Nifedipine: more than a calcium channel blocker. Gen Pharmacol 17(3):255\u2013260","journal-title":"Gen Pharmacol"},{"issue":"1\u20133","key":"9924_CR43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2007.04.033","volume":"568","author":"RW Li","year":"2007","unstructured":"Li RW, Tse CM, Man RY, Vanhoutte PM, Leung GP (2007) Inhibition of human equilibrative nucleoside transporters by dihydropyridine-type calcium channel antagonists. Eur J Pharmacol 568(1\u20133):75\u201382","journal-title":"Eur J Pharmacol"},{"key":"9924_CR44","doi-asserted-by":"publisher","first-page":"H189","DOI":"10.1152\/ajpheart.00217.2019","volume":"318","author":"DE Le","year":"2020","unstructured":"Le DE, Davis CM, Wei K, Zhao Y, Cao Z, Nugent M, Scott KLL, Liu L, Nagarajan S, Alkayed NJ et al (2020) Ranolazine may exert its beneficial effects by increasing myocardial adenosine levels. Am J Physiol Heart Circ Physiol 318:H189\u2013H202","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9924_CR45","doi-asserted-by":"publisher","first-page":"7425","DOI":"10.1038\/s41380-021-01246-3","volume":"26","author":"V Lazarevic","year":"2021","unstructured":"Lazarevic V, Yang Y, Flais I et al (2021) Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors. Mol Psychiatry 26:7425\u20137435. https:\/\/doi.org\/10.1038\/s41380-021-01246-3","journal-title":"Mol Psychiatry"},{"key":"9924_CR46","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1097\/00000542-200506000-00017","volume":"102","author":"J Mazar","year":"2005","unstructured":"Mazar J, Rogachev B, Shaked G, Ziv NY, Czeiger D, Chaimovitz C, Zlotnik M, Mukmenev I, Byk G, Douvdevani A (2005) Involvement of adenosine in the antiinflammatory action of ketamine. Anesthesiology 102:1174\u20131181","journal-title":"Anesthesiology"},{"issue":"2","key":"9924_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11302-013-9391-2","volume":"10","author":"A Ramadan","year":"2014","unstructured":"Ramadan A, Naydenova Z, Stevanovic K, Rose JB, Coe IR (2014) The adenosine transporter, ENT1, in cardiomyocytes is sensitive to inhibition by ethanol in a kinase-dependent manner: implications for ethanol-dependent cardioprotection and nucleoside analog drug cytotoxicity. Purinergic Signal 10(2):305\u2013312","journal-title":"Purinergic Signal"},{"key":"9924_CR48","doi-asserted-by":"publisher","first-page":"10487","DOI":"10.1523\/JNEUROSCI.22-23-10487.2002","volume":"22","author":"M Naassila","year":"2002","unstructured":"Naassila M, Ledent C, Daoust M (2002) Low ethanol sensitivity and increased ethanol consumption in mice lacking adenosine A2A receptors. J Neurosci 22:10487\u201310493","journal-title":"J Neurosci"},{"key":"9924_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10059-013-0192-9","volume":"36","author":"HW Nam","year":"2013","unstructured":"Nam HW, Bruner RC, Choi DS (2013) Adenosine signaling in striatal circuits and alcohol use disorders. Mol Cells 36:195\u2013202. https:\/\/doi.org\/10.1007\/s10059-013-0192-9","journal-title":"Mol Cells"},{"key":"9924_CR50","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.pnpbp.2008.01.012","volume":"32","author":"KR Lobato","year":"2010","unstructured":"Lobato KR, Binfar\u00e9 RW, Budni J, Rosa AO, Santos ARS, Rodrigues ALS (2010) Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test. Prog Neuro-Psychopharmacol Biol Psych 32:994\u2013999","journal-title":"Prog Neuro-Psychopharmacol Biol Psych"},{"key":"9924_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4097\/kja.d.18.00022","volume":"72","author":"Y Kim","year":"2019","unstructured":"Kim Y, Kwon SY, Jung HS, Park YJ, Kim YS, In JH, Choi JW, Kim JA, Joo JD (2019) Amitriptyline inhibits the MAPK\/ERK and CREB pathways and proinflammatory cytokines through A3AR activation in rat neuropathic pain models. Korean J Anesthesiol 72:60\u201367. https:\/\/doi.org\/10.4097\/kja.d.18.00022","journal-title":"Korean J Anesthesiol"},{"issue":"6","key":"9924_CR52","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1074\/jbc.275.6.4429","volume":"275","author":"CA Salvatore","year":"2000","unstructured":"Salvatore CA, Tilley SL, Latour AM, Fletcher DS, Koller BH, Jacobson MA (2000) Disruption of the A3 adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem 275(6):4429\u20134434","journal-title":"J Biol Chem"},{"issue":"2","key":"9924_CR53","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1124\/jpet.115.229872","volume":"356","author":"JL Carlin","year":"2016","unstructured":"Carlin JL, Tosh DK, Xiao C, Pinol RA, Chen Z, Salvemini D et al (2016) Peripheral adenosine A3 receptor activation causes regulated hypothermia in mice that is dependent on central histamine H1 receptors. J Pharmacol Exp Ther 356(2):474\u2013482","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"9924_CR54","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1476-5381.1994.tb17151.x","volume":"113","author":"R Anderson","year":"1994","unstructured":"Anderson R, Sheehan MJ, Strong P (1994) Characterization of the adenosine receptors mediating hypothermia in the conscious mouse. Br J Pharmacol 113(4):1386\u20131390","journal-title":"Br J Pharmacol"},{"issue":"3","key":"9924_CR55","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1254\/jphs.SC0040178","volume":"97","author":"M Shintani","year":"2005","unstructured":"Shintani M, Tamura Y, Monden M, Shiomi H (2005) Characterization of N6-cyclohexyladenosine-induced hypothermia in Syrian hamsters. J Pharmacol Sci 97(3):451\u2013454","journal-title":"J Pharmacol Sci"},{"issue":"36","key":"9924_CR56","doi-asserted-by":"publisher","first-page":"14512","DOI":"10.1523\/JNEUROSCI.1980-13.2013","volume":"33","author":"D Tupone","year":"2013","unstructured":"Tupone D, Madden CJ, Morrison SF (2013) Central activation of the A1 adenosine receptor (A1AR) induces a hypothermic, torpor-like state in the rat. J Neurosci 33(36):14512\u201314525","journal-title":"J Neurosci"},{"issue":"12","key":"9924_CR57","doi-asserted-by":"publisher","first-page":"e0243986","DOI":"10.1371\/journal.pone.0243986","volume":"15","author":"HS Province","year":"2020","unstructured":"Province HS, Xiao C, Mogul AS, Sahoo A, Jacobson KA, Pinol RA et al (2020) Activation of neuronal adenosine A1 receptors causes hypothermia through central and peripheral mechanisms. PLoS ONE 15(12):e0243986","journal-title":"PLoS ONE"},{"issue":"6643","key":"9924_CR58","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/41771","volume":"388","author":"C Ledent","year":"1997","unstructured":"Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ et al (1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388(6643):674\u2013678","journal-title":"Nature"},{"key":"9924_CR59","doi-asserted-by":"publisher","first-page":"15129","DOI":"10.1038\/s41598-021-94607-5","volume":"11","author":"SKS Bhagavatham","year":"2021","unstructured":"Bhagavatham SKS, Khanchandani P, Kannan V et al (2021) Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis. Sci Rep 11:15129. https:\/\/doi.org\/10.1038\/s41598-021-94607-5","journal-title":"Sci Rep"},{"issue":"3","key":"9924_CR60","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0091-3057(02)00840-7","volume":"73","author":"MF Jarvis","year":"2002","unstructured":"Jarvis MF, Mikusa J, Chu KL, Wismer CT, Honore P, Kowaluk EA et al (2002) Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats. Pharmacol Biochem Behav 73(3):573\u2013581","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"9924_CR61","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11302-015-9460-9","volume":"11","author":"MW Alnouri","year":"2015","unstructured":"Alnouri MW, Jepards S, Casari A, Schiedel AC, Hinz S, Muller CE (2015) Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors. Purinergic Signal 11(3):389\u2013407","journal-title":"Purinergic Signal"},{"key":"9924_CR62","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fimmu.2012.00134","volume":"3","author":"N Rudich","year":"2012","unstructured":"Rudich N, Ravid K, Sagi-Eisenberg R (2012) Mast cell adenosine receptors function: a focus on the A3 adenosine receptor and inflammation. Front Immunol 3:134","journal-title":"Front Immunol"},{"issue":"10","key":"9924_CR63","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1440-1681.2011.05550.x","volume":"38","author":"Y Bai","year":"2011","unstructured":"Bai Y, Muqier Murakami H, Iwasa M, Sumi S, Yamada Y, Minatoguchi S (2011) Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels. Clin Exp Pharmacol Physiol 38(10):658\u2013665","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"20","key":"9924_CR64","doi-asserted-by":"publisher","first-page":"e121521","DOI":"10.1172\/jci.insight.121521","volume":"3","author":"CM Aherne","year":"2018","unstructured":"Aherne CM, Collins CB, Rapp CR, Olli KE, Perrenoud L, Jedlicka P, Bowser JL, Mills TW, Karmouty-Quintana H, Blackburn MR, Eltzschig HK (2018) Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation. JCI Insight 3(20):e121521. https:\/\/doi.org\/10.1172\/jci.insight.121521","journal-title":"JCI Insight"},{"issue":"8","key":"9924_CR65","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1096\/fj.13-228551","volume":"27","author":"T Eckle","year":"2013","unstructured":"Eckle T, Hughes K, Ehrentraut H, Brodsky KS, Rosenberger P, Choi DS, Ravid K, Weng T, Xia Y, Blackburn MR, Eltzschig HK (2013) Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury. FASEB J 27(8):3078\u20133089. https:\/\/doi.org\/10.1096\/fj.13-228551","journal-title":"FASEB J"},{"key":"9924_CR66","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2459\/JCM.0b013e3283439746","volume":"12","author":"N Kanlop","year":"2011","unstructured":"Kanlop N, Chattipakorn S, Chattipakorn N (2011) Effects of cilostazol in the heart. J Cardiovasc Med 12:88\u201395","journal-title":"J Cardiovasc Med"},{"key":"9924_CR67","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/jcpt.13284","volume":"46","author":"Y Xue","year":"2021","unstructured":"Xue Y, Wang Z, Wu H, Li X, Chen J, Lv Q (2021) Cilostazol increases adenosine plasma concentration in patients with acute coronary syndrome. J Clin Pharm Ther 46:328\u2013332. https:\/\/doi.org\/10.1111\/jcpt.13284","journal-title":"J Clin Pharm Ther"},{"key":"9924_CR68","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nn1288","volume":"7","author":"DS Choi","year":"2004","unstructured":"Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, McMahon T, Messing RO (2004) The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci 7:855\u2013861","journal-title":"Nat Neurosci"},{"issue":"7","key":"9924_CR69","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/s0028-3908(03)00254-5","volume":"45","author":"M El Yacoubi","year":"2003","unstructured":"El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM (2003) Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade. Neuropharmacology 45(7):977\u2013985. https:\/\/doi.org\/10.1016\/s0028-3908(03)00254-5","journal-title":"Neuropharmacology"},{"issue":"6","key":"9924_CR70","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/01616412.2016.1187826","volume":"38","author":"K Liu","year":"2016","unstructured":"Liu K, Khan H, Geng X, Zhang J, Ding Y (2016) Pharmacological hypothermia: a potential for future stroke therapy? Neurolog Res 38(6):478\u2013490. https:\/\/doi.org\/10.1080\/01616412.2016.1187826","journal-title":"Neurolog Res"},{"issue":"2","key":"9924_CR71","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00109-012-0988-7","volume":"91","author":"JM Poth","year":"2013","unstructured":"Poth JM, Brodsky K, Ehrentraut H, Grenz A, Eltzschig HK (2013) Transcriptional control of adenosine signaling by hypoxia-inducible transcription factors during ischemic or inflammatory disease. J Mol Med (Berl) 91(2):183\u2013193. https:\/\/doi.org\/10.1007\/s00109-012-0988-7","journal-title":"J Mol Med (Berl)"},{"key":"9924_CR72","first-page":"312","volume":"123","author":"DG Nathan","year":"2012","unstructured":"Nathan DG, Field J, Lin G, Neuberg D, Majerus E, Onyekwere O, Keefer J, Okam M, Ross A, Linden J (2012) Sickle cell disease (SCD), iNKT cells, and regadenoson infusion. Trans Am Clin Climatol Assoc 123:312\u2013317 (discussion 317-318)","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"3","key":"9924_CR73","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11060-017-2404-1","volume":"132","author":"S Jackson","year":"2017","unstructured":"Jackson S, George RT, Lodge MA, Piotrowski A, Wahl RL, Gujar SK, Grossman SA (2017) The effect of regadenoson on the integrity of the human blood-brain barrier, a pilot study. J Neurooncol 132(3):513\u2013519. https:\/\/doi.org\/10.1007\/s11060-017-2404-1","journal-title":"J Neurooncol"},{"key":"9924_CR74","doi-asserted-by":"publisher","first-page":"e140971","DOI":"10.1172\/jci.insight.140971","volume":"5","author":"Y Kanthi","year":"2020","unstructured":"Kanthi Y, Knight JS, Zuo Y, Pinsky DJ (2020) New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm. JCI Insight 5:e140971","journal-title":"JCI Insight"},{"key":"9924_CR75","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nn.2562","volume":"13","author":"N Goldman","year":"2010","unstructured":"Goldman N et al (2010) Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nature Neurosci 13:883\u2013888","journal-title":"Nature Neurosci"},{"key":"9924_CR76","doi-asserted-by":"publisher","first-page":"680706","DOI":"10.3389\/fnagi.2021.680706","volume":"13","author":"Y Shi","year":"2021","unstructured":"Shi Y, Dai Q, Ji B, Huang L, Zhuang X, Mo Y, Wang J (2021) Electroacupuncture pretreatment prevents cognitive impairment induced by cerebral ischemia\u2013reperfusion via adenosine A1 receptors in rats. Front Aging Neurosci 13:680706. https:\/\/doi.org\/10.3389\/fnagi.2021.680706","journal-title":"Front Aging Neurosci"},{"key":"9924_CR77","doi-asserted-by":"publisher","first-page":"7952","DOI":"10.3390\/ijms22157952","volume":"22","author":"E Coppi","year":"2021","unstructured":"Coppi E, Cherchi F, Lucarini E, Ghelardini C, Pedata F, Jacobson KA, Di Cesare ML, Pugliese AM, Salvemini D (2021) Uncovering the mechanisms of A3 adenosine receptor-mediated pain control. Int J Mol Sci 22:7952","journal-title":"Int J Mol Sci"},{"issue":"2","key":"9924_CR78","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7(2):27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703","journal-title":"J Basic Clin Pharm"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-023-09924-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-023-09924-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-023-09924-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T03:14:28Z","timestamp":1695870868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-023-09924-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["9924"],"URL":"https:\/\/doi.org\/10.1007\/s11302-023-09924-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2386583\/v1","asserted-by":"object"}]},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"16 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were conducted with approval of the NIDDK Institutional Animal Care and Use Committee (IUCAC), protocol number K016-DEOB-23. Standards of the Association for Assessment and Accreditation of Laboratory Animal Care, International (AAALAC) were followed, and work was performed in an AAALAC-accredited facility. Human studies\u2014not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Cuiying Xiao declares that he\/she has no conflict of interest. Oksana Gavrilova declares that he\/she has no conflict of interest. Naili Liu declares that he\/she has no conflict of interest. Sarah A. Lewicki declares that he\/she has no conflict of interest. Marc L. Reitman declares that he\/she has no conflict of interest. Kenneth A. Jacobson declares that he\/she has no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}